Commentary on: Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients Isabelle Brenot-RossiCyrille Bastide Editorial Commentary 23 June 2009 Pages: 1375 - 1376
Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients G. HollR. DornJ. Sciuk Original Article 09 May 2009 Pages: 1377 - 1382
Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer S. van EsserM. HobbelinkR. van Hillegersberg Original Article Open access 25 March 2009 Pages: 1383 - 1387
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT Kazuhiro KitajimaKoji MurakamiKazuro Sugimura Original Article 16 April 2009 Pages: 1388 - 1396
Incidental head and neck 18F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development? Till A. HeusnerSteffen HahnAlexander R. Stahl Original Article 21 March 2009 Pages: 1397 - 1406
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma Mirco BartolomeiLisa BodeiGiovanni Paganelli Original Article 25 March 2009 Pages: 1407 - 1416
Staging primary head and neck cancers with 18F-FDG PET/CT: is intravenous contrast administration really necessary? Keisuke YoshidaAkiko SuzukiTomio Inoue Original Article 08 April 2009 Pages: 1417 - 1424
188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study Marnix G. E. H. LamTjitske B. BosmaBernard A. Zonnenberg Original Article Open access 25 March 2009 Pages: 1425 - 1433
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment Sebastian A. MüllerKorbinian HolzapfelReingard Senekowitsch-Schmidtke Original Article 08 April 2009 Pages: 1434 - 1442
In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study Flavio ForrerJianhua ChenHelmut R. Maecke Original Article 07 April 2009 Pages: 1443 - 1452
[18F]Fluoroacetate is not a functional analogue of [11C]acetate in normal physiology Örjan LindheAijun SunJens Sörensen Original Article 22 April 2009 Pages: 1453 - 1459
The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114mIn-mediated targeting therapy Vladimir TolmachevHelena WållbergAnna Orlova Original Article 09 May 2009 Pages: 1460 - 1468
18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK) Christina HultschMargret SchotteliusHans-Jürgen Wester Short Communication 07 April 2009 Pages: 1469 - 1474
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging Zhaofei LiuGang NiuXiaoyuan Chen Original Article 10 April 2009 Pages: 1483 - 1494
Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with 99mTc- and 123I-labelled probes M. PissarekJ. Meyer-KirchrathN. Schramm Original Article Open access 07 May 2009 Pages: 1495 - 1509
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab Gang NiuZibo LiXiaoyuan Chen Original Article 14 May 2009 Pages: 1510 - 1519
Monitoring cancer therapy with PET: probably effective, but more research is needed Giovanni Lucignani Focus on 11 July 2009 Pages: 1520 - 1525
Eugene C. Lin, Edward J. Escott, Kavita D. Garg, Andrew G. Bleicher, David Alexander: Practical differential diagnosis for CT and MRI Maurizio SaccoLuigi Mansi Book Review 11 July 2009 Pages: 1526 - 1526
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging Maurice H. ZissenAndrew Quon Image of the Month 27 June 2009 Pages: 1527 - 1527
EANM guidelines for ventilation/perfusion scintigraphy M. BajcJ. B. NeillyB. Jonson Guidelines 24 July 2009 Pages: 1528 - 1538